Newborn Screening Market to be Worth $2.69 Billion by 2031

These technologies are still in the research phase but are being tested to screen newborns. NGS screening will help in screening more disorders compared to other conventional technologies using techniques such as targeted gene panels, whole exome sequencing (WES), and whole genome sequencing (WGS). NGS technology will also follow the Wilson and Jungner principles to identify genes associated with treatable disorders. It is economically feasible, and many tools and software are available for result interpretation.